Sunday, June 21, 2020

Why India needs to reassess use of HCQ for COVID-19 treatment

Why India needs to reassess use of HCQ for COVID-19 treatment India has been using hydroxychloroquine, commonly known as HCQ, for treatment of COVID-19 patients and as prophylactic in high-risk groups such as healthcare and other frontline workers.

from Moneycontrol Business News https://ift.tt/2Nhtd8L

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...